NCT05963971
- Conditions
- Acute Lymphoblastic Leukemia, Body Weight, Hematologic Diseases, +17 more
- Locations
-
- Columbia University Medical Center New York, United States
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,978 public trials
1,830 recruiting studies
Lymphatic Diseases trial results
NCT07202091
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Austin Hospital Melbourne, Victoria, Australia
- Northern Health Melbourne, Victoria, Australia
NCT07202078
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Austin Hospital Melbourne, Victoria, Australia
- Northern Health Melbourne, Victoria, Australia
NCT07202065
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Austin Hospital Melbourne, Victoria, Australia
- Northern Health Melbourne, Victoria, Australia
NCT07202052
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Austin Hospital Melbourne, Victoria, Australia
- Northern Health Melbourne, Victoria, Australia
Recruiting
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
NCT04679012
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Mount Sinai- Icahn School of Medicine New York, United States
- Columbia University Medical Center New York, United States
- Weill Cornell Medicine New York, United States
- Ohio state University Columbus, Ohio, United States
NCT07209059
- Conditions
- Advanced Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +8 more
- Locations
-
- National Medical Research Center for Hematology Moscow, Russia
NCT06052826
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT06029309
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Miami Miami, Florida, United States
Recruiting
Orelabrutinib Combined With Zebetuzumab and Lenalidomide for the Treatment of Newly Diagnosed MZL
NCT07208981
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital Nanjing, Jiangsu, China